The Coaltion for Global Hepatitis Elimination's National Hepatitis Elimination Profiles assess the status of national data, ...

Los Angeles County is facing a community-wide outbreak of the contagious virus ... hepatitis A. The other is a three-dose vaccine that protects against both hepatitis A and hepatitis B.

Viral hepatitis is a common disease globally, but many are unaware of their status. Symptoms and transmission routes are discussed here.

A model for hepatitis B virus-associated chronic liver disease has been made using cloned hepatitis B virus DNA as a transgene in a severe combined immunodeficient host. These mice consistently ...

Vir is holding off on advancing the combination therapy to Phase III trials until it secures a development partner.

The Coalition for Global Hepatitis Elimination's National Hepatitis Elimination Profiles assess the status of national data, ...

Hepatitis is an inflammation of the liver, most commonly caused by a viral infection. The three main types—Hepatitis A, B, and C—pose different risks but can all lead to serious health complications ...

An antisense drug in development at GSK has shown further activity against hepatitis B virus (HBV) in a mid-stage trial, setting up a phase 3 assessment next year to see if it could offer a ...

Results demonstrate that in cell culture, ABI-6250 specifically inhibits both HDV and hepatitis B virus (HBV) at low nanomolar levels and shows selectivity versus a panel of other viruses. ABI-6250 ...

GSK has revealed updated results from its phase 2b trial of its antisense drug for hepatitis B virus (HBV) infections, which reveal a sharp decline in the proportion of patients with undetectable ...